Build a Heart. Save a life.
BIOLIFE4D is committed to perfecting the technology to make viable organ replacement a safe, accessible and affordable reality. With BIOLIFE4D, a patient-specific, fully functioning heart will be created through 3D bioprinting and the patient’s own cells, eliminating the challenges of organ rejection and long donor waiting lists that plague existing organ transplant methods.

BUILD A HEART SAVE A LIFE

Now Open for Investment!!

BIOLIFE4D is very excited about the overwhelming support we have received including feature articles in Crain’s Chicago, Fast Company, The Street, USA Today and other publications recently. Several thousand individuals have reserved stock and the opportunity to become an investor and shareholder has finally arrived.Bioprinter layering bio-ink of human heart cells  

Bioprinter layering bio-ink of human heart cells
BIOPRINTING
What if we could print a human heart? Science has found a way. This is not science fiction. This is science fact. This is BIOLIFE4D.

Learn More See Bioprinting in Action

Heart cell for 3D bioprinting
BIOLIFE4D PROCESS
It starts with a patient’s own cells and ends with a bioprinted heart that’s both a precise fit and perfect genetic match.

Learn More

Heart cell for 3D bioprinting
BIOLIFE4D logo
INVEST
BIOLIFE4D is now open for investors to purchase stock and participate in the development of this remarkable new process.
Invest Now Learn More Bioprinter layering bio-ink of human heart cells

BIOLIFE4D in the News!

You can 3-D print chocolate, parts of an airplane, even skin. But what about a human heart? So far, printing one that’s transplant-worthy has been an elusive goal for researchers and companies, despite rapid advancements in technology. Enter Steven Morris, founder and CEO of Skokie startup BioLife4D. He’s busy assembling a team, adding talent from…

Latest Press Releases

Agreement provides access to world class academic research facilities and resources, including sophisticated imaging and instrumentation capabilities, as Company continues development of groundbreaking bioprinting technology CHICAGO, Feb. 05, 2018 (GLOBE NEWSWIRE) — BIOLIFE4D, a biotech pioneer leveraging advances in tissue engineering to 3D print human organs viable for transplant, today announced it has signed a Laboratory…

Recent Blogs

BIOLIFE4D is pleased to announce today the availability of two new investment methods – mobile device and debit/credit cards! Investing in BIOLIFE4D has never been easier, as we have now expanded our solutions to provide investors with multiple options for investment. Mobile Devices  In addition to laptop and desktop computers, investors can now utilize their…

Build a Heart. Save a life.

Invest Now

Bioprinter layering bio-ink of human heart cells

Invest Now

Scroll Up